{
  "docId": "019de073-ed1e-723c-a28e-3c378280574e",
  "docSlug": "3439c61eec2c1805f58a361a1d0fbc84",
  "documentTitle": "ATAI | Investor Presentation Deck | 36 slides",
  "authorId": "atai",
  "authorName": "atai Life Sciences",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 35,
  "pageCount": 36,
  "prevPage": 34,
  "nextPage": 36,
  "slideType": "other",
  "function": "other",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "Page number 35. The slide uses a card-based layout to describe portfolio companies.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de073-ed1e-723c-a28e-3c378280574e/35",
  "deckHref": "/decks/019de073-ed1e-723c-a28e-3c378280574e",
  "deckJsonHref": "/decks/019de073-ed1e-723c-a28e-3c378280574e.json",
  "deckAnchorHref": "/decks/019de073-ed1e-723c-a28e-3c378280574e#slide-35",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.75,
        "x": 0.21,
        "y": 0.23
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "icon-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "526ab93e-ff10-4baf-a093-f1794fbd47cc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.23,
        "x": 0.51,
        "y": 0.25
      },
      "kind": "list",
      "text": "InnarisBio: Sol-gel based, intranasal excipient technology for nose-to-brain delivery. Joint venture with UniQuest. Non-invasive delivery avoids systemic circulation and first-pass metabolism. Benefits include patient compliance and rapid onset.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3f7322f0-e98d-49c7-a79c-43db1f2a2011",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.23,
        "x": 0.27,
        "y": 0.25
      },
      "kind": "list",
      "text": "EntheogeniX: AI-enabled computational biophysics for psychedelics-inspired mental health drugs. Joint venture with Cyclica. Uses AI to streamline drug discovery. Selects desirable targets and avoids anti-targets. Visualizes polypharmacological profiles.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "69e54976-5d2c-473e-9a0c-e6ea819e1625",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.23,
        "x": 0.75,
        "y": 0.25
      },
      "kind": "list",
      "text": "IntelGenx: OTF manufacturer in Canada with Schedule 1 license. Strategic partnership with 25% ownership. Developing OTF formulation of Viridia's VLS-01 for oromucosal absorption. Avoids stomach and first-pass metabolism.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b9c3c69d-a722-4d2c-993b-f496cc598b73",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.23,
        "x": 0.03,
        "y": 0.25
      },
      "kind": "list",
      "text": "IntroSpect: Digital therapeutics platform dedicated to improving patient outcomes through personalized care. Wholly owned platform company. Focused on digital tools for clinical psychotherapy using biomarkers. Incorporated into clinical development plans for Viridia and EmpathBio.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c3f9d35c-918b-4df9-94c7-a67850e68e42",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "Our formulation & biomarker stratification companies provide an additional avenue of growth & innovation to the atai platform",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "23ae0ee9-9e66-4322-b1e8-067c1f19bac3",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}